Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
DenovAI Biotech Logo
DenovAI Biotech Growth Score
84
CB Rank
324123
Heat Score
59
DenovAI Biotech designs protein therapeutics using artificial intelligence and computational molecular biophysics
Founded
obfuscation
Private Rehovot, HaMerkaz, Israel1-10 denovai.com
Artificial Intelligence (AI)
Biotechnology
Health Care
Medical
Overview

DenovAI Biotech
Growth Score
84
Heat Score
59

Growth Score84
-3 pts
in past quarter
Heat Score 59
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About DenovAI Biotech

CB Rank
324123
DenovAI Biotech designs protein therapeutics using artificial intelligence and computational molecular biophysics
Founded
obfuscation
Private Rehovot, HaMerkaz, Israel1-10 denovai.com
Artificial Intelligence (AI)
Biotechnology
Health Care
Medical

Key People

Details

Legal Name DenovAI Biotech, Ltd.
Operating Status Active
Company Type For Profit
Founders  Kashif Sadiq
About the Company
DenovAI is revolutionizing biologics discovery with a Gen AI-Physics platform for the de-novo design of therapeutic proteins, including antibodies and miniproteins. DenovAI’s cutting-edge technology accelerates drug discovery timelines and addressing unmet medical needs with accurately designed molecules.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AI-based Therapeutic Antibody Design Platform
An AI-driven platform for rapid de novo design of high-affinity antibodies targeting specific epitopes, reducing discovery time from months to days.
De Novo Small Protein Binder Design Platform
A platform for designing bespoke small protein binders with high affinity for specific targets, applicable in biologics and diagnostics.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 2

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

118
227.78%
 in past month

IT Spend

$8.8MThis year, DenovAI Biotech is projected to spend $8.8M on IT, according to Aberdeen.

Active Website Tech Count

3DenovAI Biotech is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Amazon Route 53.
Sub-Organizations
Frequently Asked Questions

Where is DenovAI Biotech's headquarters? DenovAI Biotech is located in Rehovot, HaMerkaz, Israel.Who are DenovAI Biotech's competitors? Alternatives and possible competitors to DenovAI Biotech may include Absci, Generate Biomedicines, and  Xaira Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|